continuous arteriovenous hemodiafiltration and hemofiltration in the treatment of tumor lysis syndrome

L. Sağlamer; H. Öz; S. Çalışkan; A. Ekinci; L. Uıukutlu; L. Sever; İ. Yıldız; B. Aykaç

EN

continuous arteriovenous hemodiafiltration and hemofiltration in the treatment of tumor lysis syndrome

Abstract

Acute tumor lysis syndrome and associated renal failure are frequently seen in children with B cell leukemia and lymphoma. In patients resistant to conservative management, renal replacement therapy is required. Continuous arteriovenous hémodiafiltration (CAVHD) and continuous arteriovenous hemofiltration (CAVH) were used successfully in the treatment of tumor lysis syndrome and renal failure preceding chemotherapy in a child with B cell leukemia. The advantages of the methods are discussed.

Keywords

Continuous arteriovenous hemofiltration,continuous arteriovenous hémodiafiltration,B cell leukemia,B cell lymphoma,tumor lysis syndrome

References

Cadman EC. Lundberg WB, Bertlno JR. Hyperphos phatemla and hypocalcemia accompanying rapid cell lysis In a patient with Burkitt's lymphoma and Burkitt cell leukemia. Am J Med 1977; 62:283-290.

Details

Primary Language

English

Subjects

Clinical Sciences

Journal Section

Research Article

Authors

L. Sağlamer This is me
Türkiye

H. Öz This is me
Türkiye

S. Çalışkan This is me
Türkiye

A. Ekinci This is me
Türkiye

L. Uıukutlu This is me
Türkiye

L. Sever This is me
Türkiye

İ. Yıldız This is me
Türkiye

B. Aykaç This is me
Türkiye

Publication Date

April 1, 1992

Submission Date

October 14, 2016

Acceptance Date

February 1, 1992

Published in Issue

Year 1992 Volume: 5 Number: 2

IZ

https://izlik.org/JA74FK86BS

Cite

RIS / Bibtex

APA

Sağlamer, L., Öz, H., Çalışkan, S., Ekinci, A., Uıukutlu, L., Sever, L., Yıldız, İ., & Aykaç, B. (1992). continuous arteriovenous hemodiafiltration and hemofiltration in the treatment of tumor lysis syndrome. Marmara Medical Journal, 5(2), 63-66. https://izlik.org/JA74FK86BS

AMA

1.Sağlamer L, Öz H, Çalışkan S, et al. continuous arteriovenous hemodiafiltration and hemofiltration in the treatment of tumor lysis syndrome. Marmara Med J. 1992;5(2):63-66. https://izlik.org/JA74FK86BS

Chicago

Sağlamer, L., H. Öz, S. Çalışkan, et al. 1992. “Continuous Arteriovenous Hemodiafiltration and Hemofiltration in the Treatment of Tumor Lysis Syndrome”. Marmara Medical Journal 5 (2): 63-66. https://izlik.org/JA74FK86BS.

EndNote

Sağlamer L, Öz H, Çalışkan S, Ekinci A, Uıukutlu L, Sever L, Yıldız İ, Aykaç B (April 1, 1992) continuous arteriovenous hemodiafiltration and hemofiltration in the treatment of tumor lysis syndrome. Marmara Medical Journal 5 2 63–66.

IEEE

[1]L. Sağlamer et al., “continuous arteriovenous hemodiafiltration and hemofiltration in the treatment of tumor lysis syndrome”, Marmara Med J, vol. 5, no. 2, pp. 63–66, Apr. 1992, [Online]. Available: https://izlik.org/JA74FK86BS

ISNAD

Sağlamer, L. - Öz, H. - Çalışkan, S. - Ekinci, A. - Uıukutlu, L. - Sever, L. - Yıldız, İ. - Aykaç, B. “Continuous Arteriovenous Hemodiafiltration and Hemofiltration in the Treatment of Tumor Lysis Syndrome”. Marmara Medical Journal 5/2 (April 1, 1992): 63-66. https://izlik.org/JA74FK86BS.

JAMA

1.Sağlamer L, Öz H, Çalışkan S, Ekinci A, Uıukutlu L, Sever L, Yıldız İ, Aykaç B. continuous arteriovenous hemodiafiltration and hemofiltration in the treatment of tumor lysis syndrome. Marmara Med J. 1992;5:63–66.

MLA

Sağlamer, L., et al. “Continuous Arteriovenous Hemodiafiltration and Hemofiltration in the Treatment of Tumor Lysis Syndrome”. Marmara Medical Journal, vol. 5, no. 2, Apr. 1992, pp. 63-66, https://izlik.org/JA74FK86BS.

Vancouver

1.L. Sağlamer, H. Öz, S. Çalışkan, A. Ekinci, L. Uıukutlu, L. Sever, İ. Yıldız, B. Aykaç. continuous arteriovenous hemodiafiltration and hemofiltration in the treatment of tumor lysis syndrome. Marmara Med J [Internet]. 1992 Apr. 1;5(2):63-6. Available from: https://izlik.org/JA74FK86BS